GSE216273 GSE216292 palbociclib 14 v 2 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE216273_GSE216292_palbociclib_14_v_2_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE216273_GSE216292_palbociclib_14_v_2_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE216273_GSE216292_palbociclib_14_v_2_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE216273_GSE216292_palbociclib_14_v_2_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

AGAP2 antisense RNA 1

Gene

tubulin alpha pseudogene 2

Gene

RAP2C pseudogene 1

Gene

SUMO specific peptidase 1

Gene

leucine rich repeat and coiled-coil centrosomal protein 1

Gene

glutaredoxin 2

Gene

apoptosis inhibitor 5

Gene

LSM11, U7 small nuclear RNA associated

Gene

solute carrier family 8 member A1

Gene

bromodomain and PHD finger containing 1

  • Gene

    AGAP2 antisense RNA 1


  • Gene

    tubulin alpha pseudogene 2


  • Gene

    RAP2C pseudogene 1


  • Gene

    SUMO specific peptidase 1


  • Gene

    leucine rich repeat and coiled-coil centrosomal protein 1



  • Gene

    apoptosis inhibitor 5


  • Gene

    LSM11, U7 small nuclear RNA associated


  • Gene

    solute carrier family 8 member A1


  • Gene

    bromodomain and PHD finger containing 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.